Cargando…
Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis
BACKGROUND: Methotrexate (MTX) intolerance is a frequent problem of long-term treatment in juvenile idiopathic arthritis (JIA). Mutations in the methylentetrahydrofolate reductase (MTHFR) gene may increase toxicity of MTX, potentially constituting an initial stimulus for this conditioned response. T...
Autores principales: | Scheuern, Andrea, Fischer, Nadine, McDonald, Joseph, Brunner, Hermine I., Haas, Johannes-Peter, Hügle, Boris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772529/ https://www.ncbi.nlm.nih.gov/pubmed/26928923 http://dx.doi.org/10.1186/s12969-016-0071-y |
Ejemplares similares
-
Intolerance in oral versus subcutaneous administration of methotrexate in patients with juvenile idiopathic arthritis: a cross-sectional, observational study
por: Van Dijkhuizen, Pieter, et al.
Publicado: (2014) -
Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing – treatment protocol and preliminary results
por: Höfel, Lea, et al.
Publicado: (2018) -
Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course
por: Hügle, Boris, et al.
Publicado: (2014) -
Inflammatory bowel disease following anti-interleukin-1-treatment in systemic juvenile idiopathic arthritis
por: Hügle, Boris, et al.
Publicado: (2017) -
α2-fraction and haptoglobin as biomarkers for disease activity in oligo- and polyarticular juvenile idiopathic arthritis
por: Zeller, Ludwig, et al.
Publicado: (2022)